BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29900754)

  • 21. Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure.
    Masson S; Batkai S; Beermann J; Bär C; Pfanne A; Thum S; Magnoli M; Balconi G; Nicolosi GL; Tavazzi L; Latini R; Thum T
    Eur J Heart Fail; 2018 Jan; 20(1):78-85. PubMed ID: 29027324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of circulating microRNAs in patients with repaired Tetralogy of Fallot with and without heart failure.
    Abu-Halima M; Meese E; Keller A; Abdul-Khaliq H; Rädle-Hurst T
    J Transl Med; 2017 Jul; 15(1):156. PubMed ID: 28693530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.
    Wang H; Chen F; Tong J; Li Y; Cai J; Wang Y; Li P; Hao Y; Tian W; Lv Y; Chong J; Yang J
    Cardiol J; 2017; 24(1):65-73. PubMed ID: 27748501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma Exosomal miR-422a and miR-125b-2-3p Serve as Biomarkers for Ischemic Stroke.
    Li DB; Liu JL; Wang W; Li RY; Yu DJ; Lan XY; Li JP
    Curr Neurovasc Res; 2017; 14(4):330-337. PubMed ID: 28982331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA-Seq Identifies Circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as Potential Biomarkers for Acute Ischemic Stroke.
    Tiedt S; Prestel M; Malik R; Schieferdecker N; Duering M; Kautzky V; Stoycheva I; Böck J; Northoff BH; Klein M; Dorn F; Krohn K; Teupser D; Liesz A; Plesnila N; Holdt LM; Dichgans M
    Circ Res; 2017 Sep; 121(8):970-980. PubMed ID: 28724745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating microribonucleic acids miR-1, miR-21 and miR-208a in patients with symptomatic heart failure: Preliminary results.
    Sygitowicz G; Tomaniak M; Błaszczyk O; Kołtowski Ł; Filipiak KJ; Sitkiewicz D
    Arch Cardiovasc Dis; 2015 Dec; 108(12):634-42. PubMed ID: 26498537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating miR-221-3p as a novel marker for early prediction of acute myocardial infarction.
    Coskunpinar E; Cakmak HA; Kalkan AK; Tiryakioglu NO; Erturk M; Ongen Z
    Gene; 2016 Oct; 591(1):90-96. PubMed ID: 27374153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentration of circulating microparticles: a new biomarker of acute heart failure after cardiac surgery with cardiopulmonary bypass.
    Li Y; Yuan H; Chen C; Chen C; Ma J; Chen Y; Li Y; Jian Y; Liu D; Ou Z; Ou J
    Sci China Life Sci; 2021 Jan; 64(1):107-116. PubMed ID: 32548691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma.
    Li M; Song Q; Li H; Lou Y; Wang L
    PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Expression of microRNAs in Acute and Chronic Heart Failure.
    Kalampogias A; Oikonomou E; Siasos G; Theofilis P; Dimitropoulos S; Gazouli M; Gennimata V; Marinos G; Charalambous G; Vavouranakis M; Tsioufis K; Tousoulis D
    Curr Med Chem; 2022 Aug; 29(30):5130-5138. PubMed ID: 35473531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Circulating miR-150 is a Predictor of Post-Acute Myocardial Infarction Heart Failure.
    Lin X; Zhang S; Huo Z
    Int Heart J; 2019 Mar; 60(2):280-286. PubMed ID: 30745540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis.
    Ormseth MJ; Solus JF; Vickers KC; Oeser AM; Raggi P; Stein CM
    J Rheumatol; 2015 Oct; 42(10):1746-1751. PubMed ID: 26233505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing a panel of biomarkers and miRNA in patients with myocardial infarction for early intervention strategies of heart failure in West Virginian population.
    Lakhani HV; Khanal T; Gabi A; Yousef G; Alam MB; Sharma D; Aljoudi H; Puri N; Thompson E; Shapiro JI; Sodhi K
    PLoS One; 2018; 13(10):e0205329. PubMed ID: 30356307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating microRNA Signatures in Patients With Idiopathic and Postmenopausal Osteoporosis and Fragility Fractures.
    Kocijan R; Muschitz C; Geiger E; Skalicky S; Baierl A; Dormann R; Plachel F; Feichtinger X; Heimel P; Fahrleitner-Pammer A; Grillari J; Redl H; Resch H; Hackl M
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4125-4134. PubMed ID: 27552543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating pro-angiogenic and anti-angiogenic microRNA expressions in patients with acute ischemic stroke and their association with disease severity.
    Jin F; Xing J
    Neurol Sci; 2017 Nov; 38(11):2015-2023. PubMed ID: 28875333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure.
    Vegter EL; Ovchinnikova ES; Silljé HHW; Meems LMG; van der Pol A; van der Velde AR; Berezikov E; Voors AA; de Boer RA; van der Meer P
    PLoS One; 2017; 12(5):e0177242. PubMed ID: 28475616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between NT-proBNP levels, functional capacity and stage in patients with heart failure.
    Karabulut A; Kaplan A; Aslan C; Iltumur K; Toprak G; Toprak N
    Acta Cardiol; 2005 Dec; 60(6):631-8. PubMed ID: 16385925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
    Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
    Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.